Rejuvel Bio-Sciences, Inc. (NUUU) financial statements (2022 and earlier)

Company profile

Business Address CHASE BANK BUILDING 150 SE 2ND AVE
MIAMI, FL 33131
State of Incorp. FL
Fiscal Year End December 31
SIC 519 - Miscellaneous Non-durable Goods (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

9/30/2015
Q3
6/30/2015
Q2
3/31/2015
Q1
12/31/2014
Q4
9/30/2014
Q3
6/30/2014
Q2
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments1234440188173
Cash and cash equivalents1234440188173
Receivables00    
Inventory, net of allowances, customer advances and progress billings35242259888
Inventory35242259888
Other current assets461591082122
Other undisclosed current assets7777117
Total current assets:8921318053309269
Noncurrent Assets
Property, plant and equipment696763626042
Intangible assets, net (including goodwill)1415151622
Intangible assets, net (excluding goodwill)1415151622
Other undisclosed noncurrent assets(37)(34)(29)(26)(27)(24)
Total noncurrent assets:464850523621
TOTAL ASSETS:134260230105344290
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:601545488459433353
Interest and dividends payable2428    
Other undisclosed accounts payable and accrued liabilities577517488459433353
Debt    15 
Derivative instruments and hedges, liabilities46844224149148668
Due to related parties7777 777777
Deferred revenue and credits   3  
Other liabilities162   
Other undisclosed current liabilities555457431350368336
Total current liabilities:1,7021,5281,1629381,0421,435
Noncurrent Liabilities
Long-term debt and lease obligation5     
Long-term debt, excluding current maturities5     
Total noncurrent liabilities:5     
Total liabilities:1,7071,5281,1629381,0421,435
Stockholders' equity
Stockholders' equity attributable to parent(1,573)(1,267)(932)(833)(698)(1,145)
Common stock5151505050119
Additional paid in capital1,7351,7121,4201,2741,5581,218
Accumulated deficit(3,358)(3,031)(2,403)(2,158)(2,306)(2,481)
Total stockholders' equity:(1,573)(1,267)(932)(833)(698)(1,145)
TOTAL LIABILITIES AND EQUITY:134260230105344290

Income statement (P&L) ($ in thousands)

9/30/2015
Q3
6/30/2015
Q2
3/31/2015
Q1
12/31/2014
Q4
9/30/2014
Q3
6/30/2014
Q2
Revenues503670301843
Cost of revenue(10)(5)(9)(74)(0)(6)
Cost of goods and services sold(5)     
Gross profit:403161(44)1837
Operating expenses(276)(605)(274)(308)(211)(162)
Other undisclosed operating income  2731  
Operating income (loss):(236)(574)(211)379(193)(125)
Nonoperating income (expense)
(Investment Income, Nonoperating)
(115)(117)(64)258(258)(15)
Interest and debt expense(296)98(267)5310
Net income (loss):(646)(593)(542)642(448)(130)
Other undisclosed net income (loss) attributable to parent318(35)297(494)6231,842
Net income (loss) available to common stockholders, diluted:(328)(628)(245)1481751,711

Comprehensive Income ($ in thousands)

9/30/2015
Q3
6/30/2015
Q2
3/31/2015
Q1
12/31/2014
Q4
9/30/2014
Q3
6/30/2014
Q2
Net income (loss):(646)(593)(542)642(448)(130)
Comprehensive income (loss), net of tax, attributable to parent:(646)(593)(542)642(448)(130)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: